Journal of Andrology Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seftel, A. D.
Right arrow Articles by Smith, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seftel, A. D.
Right arrow Articles by Smith, T. M.
Journal of Andrology, Vol. 25, No. 6, November/December 2004
Copyright © American Society of Andrology

Restorative Increases in Serum Testosterone Levels Are Significantly Correlated to Improvements in Sexual Functioning

ALLEN D. SEFTEL*, RANDALL J. MACK{dagger}, ALLEN R. SECREST{dagger} AND TED M. SMITH{dagger}

From the * Department of Urology, Case Western Reserve University, University Hospitals of Cleveland, Cleveland VA Medical Center, Cleveland, Ohio; and {dagger} Auxilium Pharmaceuticals, Inc, Norristown, Pennsylvania.

Correspondence to: Allen D. Seftel, Department of Urology, Case Western Reserve University, University Hospitals of Cleveland, Cleveland VA Medical Center, 11100 Euclid Ave, Cleveland, OH 44106-5046 (e-mail: ads6{at}po.cwru.edu).


It is recognized that testosterone (T) levels decrease in men with age, as does sexual function. We hypothesize that T supplementation in hypogonadal men with sexual dysfunction will restore certain elements of sexual function. Hypogonadal male subjects (total T ≤ 300 ng/dL, n = 406, mean age 58 years) reporting one or more symptoms of low testosterone were randomized to T gel (50 mg/d and 100 mg/d), T patch, or placebo. Twenty-four–hour pharmacokinetic profiles for T were obtained. The 3 primary end points evaluated at 30 and 90 days posttreatment included a significant change in the frequency of intercourse and nighttime erections per 7-day week as well as a change in sexual desire measured on a Likert-type scale and calculated as a mean daily score. At day 30, a significant increase from baseline in sexual desire was noted for those on 100 mg/d T gel compared with those on 50 mg/d T gel, T patch, or placebo (1.2 vs 0.4, 0.7, and 0.4, respectively). A significant increase from baseline in the frequency of nighttime erections was also noted for those on 100 mg/d T gel compared with those on 50 mg/d T gel or placebo (51% of subjects in the 100 mg/d T gel group had an increase in frequency vs 30% for the 50 mg/d T gel group and 26% in the placebo group). Finally, a significant increase from baseline in the frequency of intercourse was evidenced for those on 100 mg/d T gel compared with those on T patch or placebo (39% of subjects in the 100 mg/d T gel group had an increase in frequency vs 21% for the T patch group and 24% in the placebo group). Similar results were seen for 100 mg/d T gel at day 90 for sexual desire and nighttime erections vs placebo. These data demonstrate a clear relationship between restoring serum T concentrations and improvement in certain parameters of sexual function. We propose that threshold T levels are needed in order to significantly affect improvements in sexual functioning.

     Key words: Randomized controlled trial, androgen, gel, hypogonadism, sexual dysfunction




This article has been cited by other articles:


Home page
AMERICAN JOURNAL OF LIFESTYLE MEDICINEHome page
M. Wald, M. Miner, and A. D. Seftel
State of the Art Reviews: Male Menopause: Fact or Fiction?
American Journal of Lifestyle Medicine, April 1, 2008; 2(2): 132 - 141.
[Abstract] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. G. Travison, J. E. Morley, A. B. Araujo, A. B. O'Donnell, and J. B. McKinlay
The Relationship between Libido and Testosterone Levels in Aging Men
J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2509 - 2513.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Bhasin, G. R. Cunningham, F. J. Hayes, A. M. Matsumoto, P. J. Snyder, R. S. Swerdloff, and V. M. Montori
Testosterone Therapy in Adult Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 1995 - 2010.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by The American Society of Andrology.